Beyond playing games: nephrologist vs machine in pediatric dialysis prescribing
- PMID: 30003314
- PMCID: PMC6132900
- DOI: 10.1007/s00467-018-4021-4
Beyond playing games: nephrologist vs machine in pediatric dialysis prescribing
Abstract
In a recent article in Pediatric Nephrology, Olivier Niel and colleagues applied an artificial intelligence algorithm to a clinical problem that continues to challenge experienced pediatric nephrologists: optimizing the target weight of children on dialysis. They compared blood pressure, antihypertensive medication and intradialytic symptoms in children whose target weight was prescribed firstly by a nephrologist, then subsequently using a machine learning algorithm. Improvements in all outcome measures are reported. Their innovative approach to tackling this important clinical problem appears promising. In this editorial, we discuss the strengths and weaknesses of their study and consider to what extent machine learning strategies are suited to optimizing pediatric dialysis outcomes.
Keywords: Artificial intelligence; Body water; Child; Machine learning; Renal dialysis.
Conflict of interest statement
The authors declare that they have no conflict of interest.
Comment on
-
Artificial intelligence outperforms experienced nephrologists to assess dry weight in pediatric patients on chronic hemodialysis.Pediatr Nephrol. 2018 Oct;33(10):1799-1803. doi: 10.1007/s00467-018-4015-2. Epub 2018 Jul 9. Pediatr Nephrol. 2018. PMID: 29987454
References
-
- Silver D, Schrittwieser J, Simonyan K, Antonoglou I, Huang A, Guez A, Hubert T, Baker L, Lai M, Bolton A, Chen Y, Lillicrap T, Hui F, Sifre L, van den Driessche G, Graepel T, Hassabis D. Mastering the game of Go without human knowledge. Nature. 2017;550:354–359. doi: 10.1038/nature24270. - DOI - PubMed
-
- Barbieri C, Molina M, Ponce P, Tothova M, Cattinelli I, Ion Titapiccolo J, Mari F, Amato C, Leipold F, Wehmeyer W, Stuard S, Stopper A, Canaud B. An international observational study suggests that artificial intelligence for clinical decision support optimizes anemia management in hemodialysis patients. Kidney Int. 2016;90:422–429. doi: 10.1016/j.kint.2016.03.036. - DOI - PubMed
-
- Vifor Fresenius Medical Care Renal Pharma. Artificial Intelligence for optimal anemia management in end-stage renal disease: the Anemia Control Model (ACM) Trial (ANEMEX) (https://www.clinicaltrials.gov/ct2/show/NCT03214627 accessed 29 Jun 2018)
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases